Journal Indexes Journal Indexes
Saved0
All
By index By subject →

Citation indexes

ScopusQ1–Q4 quartiles, CiteScore Web of ScienceSCIE, SSCI, AHCI, ESCI

Business rankings

ABDCRated A* to C ABS / AJGGraded 4* to 1

Open access

DOAJOpen-access journals

Elite lists

UTD 24UT Dallas research list FT50Financial Times 50

India

ONOSRead and publish free
Article IndexesAuthor Indexes
Journal FinderFind, vet and target the right journalKey Journal IndexesFT50, ABDC, Scopus, WoS and DOAJ explainedPredatory Journal CheckerRed flags, lists and tools before you submitPublication Fees (APC)What Scopus journals charge, free ones firstData ReportsOriginal numbers on fees and Scopus coverageMethodologySources, dates and how journals are matchedIndex ChangesWhat was added to or removed from each index
Sources BlogCommunityAbout Saved0
November 2026 52,300 journals indexed.
Back
Share
Visit journal website ↗ Community

Compare journals

    Get an email when this journal's indexing changes

    Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.

    Cardiovascular Drugs and Therapy

    Cardiovascular Drugs and Therapy is Scopus-indexed (Q1, CiteScore 9), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer.

    Checked against the index lists dated 2 November 2026.

    ISSN 0920-3206Verify ISSN ↗1573-7241Verify ISSN ↗

    Publisher: Springer

    Scopus · Q1WoS · SCIEONOS
    9
    CiteScore 2025
    Scopus
    Q1
    Best quartile
    rank 28 of 278 · 90th pctile
    2
    Indexed in
    major indexes

    Cost to publish: About US$4,490 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free

    ScopusElsevier Scopus
    Status
    Active
    Coverage
    1987–present
    Source type
    Journal
    Open access
    No
    CiteScore
    9
    SJR · SCImago
    1.016
    Q1 SJR quartile
    H-index
    85
    Best quartile
    Q1 · 90th pctile
    Subject areaRankPctileQ
    Pharmacology (medical)28 / 27890thQ1
    Cardiology and Cardiovascular Medicine49 / 40988thQ1
    Pharmacology45 / 32886thQ1
    View this source on Scopus.com
    Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
    Collections
    SCIE
    Categories
    Cardiac & Cardiovascular SystemPharmacology & Pharmacy
    View this source on Web of Science Check JIF in JCR
    DOAJDirectory of Open Access Journals (live)
    Not in DOAJ
    Open accessNot registered as fully open access
    ONOS · SubscriptionOne Nation One Subscription — full-text access
    This journal is part of the ONOS national subscription — readers at an ONOS-subscribed Indian institution get full-text access to its articles at no cost.
    Access depends on your institution’s ONOS participation; the subscribed title list is subject to revision.
    Learn about ONOS

    Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)

    Quick answers

    Is Cardiovascular Drugs and Therapy indexed in Scopus?

    Yes — actively indexed in Scopus, coverage 1987–present, best quartile Q1, CiteScore 9.

    What quartile is Cardiovascular Drugs and Therapy in Scopus?

    Cardiovascular Drugs and Therapy is Q1 in Pharmacology (medical) (rank 28 of 278), Q1 in Cardiology and Cardiovascular Medicine (rank 49 of 409) and Q1 in Pharmacology (rank 45 of 328), by CiteScore 2025.

    What is the impact factor of Cardiovascular Drugs and Therapy?

    Cardiovascular Drugs and Therapy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 9, which places it in quartile Q1 at the 90th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.016, quartile Q1, with an H-index of 85.

    How much does it cost to publish in Cardiovascular Drugs and Therapy?

    The publisher lists an article processing charge of about US$4,490 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.

    Who publishes Cardiovascular Drugs and Therapy and what is its ISSN?

    Cardiovascular Drugs and Therapy is published by Springer. Its print ISSN is 0920-3206 and its online ISSN is 1573-7241.

    Is Cardiovascular Drugs and Therapy covered under ONOS in India?

    Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.

    Is Cardiovascular Drugs and Therapy in Web of Science?

    Yes — indexed in the Science Citation Index Expanded.

    Is Cardiovascular Drugs and Therapy open access?

    No — it is not registered as an open-access journal in DOAJ or Scopus.

    How well cited is Cardiovascular Drugs and Therapy? — open metrics via OpenAlex

    Cardiovascular Drugs and Therapy has an h-index of 98 and a 2-year mean of 2.84 citations per paper (OpenAlex). Its Scopus CiteScore is 9, quartile Q1. On 2-year citations it ranks #85 of 271 Scopus journals in Pharmacology (medical).

    98
    h-index
    2.84
    2-yr mean citations
    1,806
    i10-index
    3,977
    works indexed
    72,043
    total citations
    Publication fee · open access list price, US$
    US$4,490
    05001,0002,0003,000+
    2-yr mean citations, among Scopus journals in the same subject
    #85 of 271 Top 32% Pharmacology (medical)
    #73 of 398 Top 19% Cardiology and Cardiovascular Medicine
    #125 of 319 Top 40% Pharmacology
    Papers published per year
    01002002017: 57 papers5720172018: 77 papers7720182019: 82 papers8220192020: 188 papers18820202021: 171 papers17120212022: 127 papers12720222023: 122 papers12220232024: 121 papers12120242025: 161 papers16120252026: 131 papers so far1312026*

    Cardiovascular Drugs and Therapy published 161 papers in 2025; its busiest recent year was 2020 with 188. 2026* is the year so far.

    Main topics
    Cardiac electrophysiology and arrhythmiasHeart Failure Treatment and ManagementCardiovascular Function and Risk FactorsCardiac Ischemia and Reperfusion

    h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.

    Who publishes in Cardiovascular Drugs and Therapy? — latest 97 articles, 2026

    In its latest 97 research articles (2026), authors are most often from China (56.7%), Pakistan (9.3%) and United States (5.2%). More than half of recent authorship comes from one country.

    Author countriesChinaChina56.7%PakistanPakistan9.3%United StatesUnited States5.2%ItalyItaly3.6%PolandPoland3.4%United KingdomUnited Kingdom3.4% Most frequent institutions (papers)Hebei Medical UniversityHebei Medical University4Zhejiang Chinese Medical UniversityZhejiang Chinese Medical Univer…3Ayub Medical CollegeAyub Medical College3Shandong University of Traditional Chinese MedicineShandong University of Traditio…3Hebei General HospitalHebei General Hospital3

    Countries are counted fractionally, so a paper by authors from two countries counts half to each.

    Are there integrity warnings for Cardiovascular Drugs and Therapy? — indicators, not proof of misconduct

    Scopus status: Active. 2 retracted papers are recorded (0.5 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.

    • Scopus statusActive
    • Retracted papers 2 · 0.5 per 1,000 papers
    • Problematic Paper Screener flags None flagged
    • Author concentration56.7% of recent authorship from China

    Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.

    Official sources & links

    Journal website ↗ Scopus source ↗ Web of Science ↗ ISSN Portal · 0920-3206 ↗ISSN Portal · 1573-7241 ↗

    Community experience: reader comments on this journal

    Comments load as you scroll here.

    Related journals

    8 journals
    Journal Indexed in
    Cardiovascular Engineering and Technology Scopus Q2 WoS SCIE Cardiovascular Intervention and Therapeutics Scopus Q2 WoS ESCI Cardiovascular Toxicology Scopus Q1 WoS SCIE Catalysis Surveys from Asia Scopus Q2 WoS SCIE Cell Biochemistry and Biophysics Scopus Q3 WoS SCIE Cell Regeneration Scopus Q1 WoS ESCI DOAJ Cellular and Molecular Bioengineering Scopus Q2 WoS SCIE Cellular and Molecular Neurobiology Scopus Q1 WoS SCIE
    ← Back to Journal Finder

    Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.

    Journal Indexes

    Free lookup of 52,000+ academic journals across Scopus, Web of Science, ABDC, ABS / AJG, DOAJ, FT50, UT Dallas 24 and ONOS — check a journal before you submit.

    Research

    Journal Finder Journals by Subject Publishing Toolkit Key Journal Indexes Predatory Journal Checker Publication Fees (APC)

    Monthly Visitors

    ···

      Contact us

      Questions or feedback? Let's talk.

      We read every message — typically replying within 48 hours.

      Send us a message

      Or write to contact@journalindexes.com

      Parent siteYuvijenyuvijen.com

      On Yuvijen

      Learn

      Free Books Blog Data Analytics

      Tools

      Periodic Table Element Reference Distributions P-Value Calculator Sample Size Calculator

      Exam Prep

      Exam Prep Hub UGC NET IPMAT CAT CBSE Class 8

      © 2026 Journal Indexes, a Yuvijen project. All rights reserved. · About Journal Indexes · Methodology · Reports · Community · Terms · Privacy